About atogepant
Calcitonin gene-related peptide receptor antagonist
Used for
- Prevention of episodic migraine in adults.
- Prevention of chronic migraine in adults.
Usual adult dose
60 mg by mouth once daily for migraine prevention.
Common side effects
- Nausea
- Constipation
- Fatigue or sleepiness
- Weight loss
Important warnings
- Avoid in severe liver impairment.
- Dose adjustment may be needed with certain medicines or kidney impairment.
- Seek urgent care for signs of a serious allergic reaction.
Pregnancy
Human pregnancy information is limited; use is generally avoided unless a clinician determines it is necessary.
Breastfeeding
It is unknown whether atogepant passes into breast milk; discuss potential risks with a healthcare professional.
Interactions
- Strong or moderate CYP3A4 inhibitors can increase atogepant levels.
- CYP3A4 inducers can reduce atogepant levels and effectiveness.
- OATP inhibitors can increase atogepant levels.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.